Literature DB >> 9754819

Mutation screening in 18 Caucasian families suggest the existence of other MODY genes.

J C Chèvre1, E H Hani, P Boutin, M Vaxillaire, H Blanché, N Vionnet, V C Pardini, J Timsit, E Larger, G Charpentier, D Beckers, M Maes, C Bellanné-Chantelot, G Velho, P Froguel.   

Abstract

Maturity-onset diabetes of the young (MODY) is a heterogeneous subtype of non-insulin-dependent diabetes mellitus characterised by early onset, autosomal dominant inheritance and a primary defect in insulin secretion. To date five MODY genes have been identified: hepatocyte nuclear factor-4 alpha (HNF-4alpha/MODY1/TCF14) on chromosome 20q, glucokinase (GCK/MODY2) on chromosome 7p, hepatocyte nuclear factor-1 alpha (HNF-1alpha/MODY3/TCF1) on chromosome 12q, insulin promoter factor-1 (IPF1/MODY4) on chromosome 13q and hepatocyte nuclear factor-1 beta (HNF-1beta/MODY5/TCF2) on chromosome 17cen-q. We have screened the HNF-4alpha, HNF-1alpha and HNF-1beta genes in members of 18 MODY kindreds who tested negative for glucokinase mutations. Five missense (G31D, R159W, A161T, R200W, R271W), one substitution at the splice donor site of intron 5 (IVS5nt + 2T-->A) and one deletion mutation (P379fsdelT) were found in the HNF-1alpha gene, but no MODY-associated mutations were found in the HNF-4alpha and HNF-1beta genes. Of 67 French MODY families that we have now studied, 42 (63%) have mutations in the glucokinase gene, 14 (21%) have mutations in the HNF-1alpha gene, and 11 (16%) have no mutations in the HNF-4alpha, IPF1 and HNF-1beta genes. Eleven families do not have mutations in the five known MODY genes suggesting that there is at least one additional locus that can cause MODY.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754819     DOI: 10.1007/s001250051025

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  Maturity-onset diabetes of the young (MODY): how many cases are we missing?

Authors:  B M Shields; S Hicks; M H Shepherd; K Colclough; A T Hattersley; S Ellard
Journal:  Diabetologia       Date:  2010-05-25       Impact factor: 10.122

Review 2.  Medical care from childhood to adulthood in type 1 and type 2 diabetes.

Authors:  G Costi; S Ten; N K Maclaren
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

3.  HNF1alpha controls renal glucose reabsorption in mouse and man.

Authors:  M Pontoglio; D Prié; C Cheret; A Doyen; C Leroy; P Froguel; G Velho; M Yaniv; G Friedlander
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

4.  Variation in NCB5OR: studies of relationships to type 2 diabetes, maturity-onset diabetes of the young, and gestational diabetes mellitus.

Authors:  Gitte Andersen; Lise Wegner; Christian Schack Rose; Jianxin Xie; Hao Zhu; Kevin Larade; Anders Johansen; Jakob Ek; Jeannet Lauenborg; Thomas Drivsholm; Knut Borch-Johnsen; Peter Damm; Torben Hansen; H Franklin Bunn; Oluf Pedersen
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

5.  Structural basis of disease-causing mutations in hepatocyte nuclear factor 1beta.

Authors:  Peng Lu; Geun Bae Rha; Young-In Chi
Journal:  Biochemistry       Date:  2007-10-09       Impact factor: 3.162

6.  Exome sequencing in children with clinically suspected maturity-onset diabetes of the young.

Authors:  Mustafa Tosur; Claudia Soler-Alfonso; Katie M Chan; Michael M Khayat; Shalini N Jhangiani; Qingchang Meng; Ahmad Refaey; Donna Muzny; Richard A Gibbs; David R Murdock; Jennifer E Posey; Ashok Balasubramanyam; Maria J Redondo; Aniko Sabo
Journal:  Pediatr Diabetes       Date:  2021-08-19       Impact factor: 4.866

7.  Human mutation within Per-Arnt-Sim (PAS) domain-containing protein kinase (PASK) causes basal insulin hypersecretion.

Authors:  Francesca Semplici; Martine Vaxillaire; Sarah Fogarty; Meriem Semache; Amélie Bonnefond; Ghislaine Fontés; Julien Philippe; Gargi Meur; Frederique Diraison; Richard B Sessions; Jared Rutter; Vincent Poitout; Philippe Froguel; Guy A Rutter
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

8.  Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3.

Authors:  Valentina Bozzoli; Maria Chiara Tisi; Luigi Pianese; Stefano Tumini; Vittoria Rufini; Maria Lucia Calcagni; Dario Pitocco; Alberto Larghi; Luigi Maria Larocca; Giuseppina Massini; Luciana Teofili; Francesco D'Alò; Stefan Hohaus
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-01-18       Impact factor: 2.576

9.  Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention.

Authors:  Gargi Meur; Albane Simon; Nasret Harun; Marie Virally; Aurélie Dechaume; Amélie Bonnefond; Sabrina Fetita; Andrei I Tarasov; Pierre-Jean Guillausseau; Trine Welløv Boesgaard; Oluf Pedersen; Torben Hansen; Michel Polak; Jean-François Gautier; Philippe Froguel; Guy A Rutter; Martine Vaxillaire
Journal:  Diabetes       Date:  2009-12-10       Impact factor: 9.461

10.  Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes.

Authors:  A Bonnefond; L Yengo; J Philippe; A Dechaume; I Ezzidi; E Vaillant; A P Gjesing; E A Andersson; S Czernichow; S Hercberg; S Hadjadj; G Charpentier; O Lantieri; B Balkau; M Marre; O Pedersen; T Hansen; P Froguel; M Vaxillaire
Journal:  Diabetologia       Date:  2012-12-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.